# DESCRIPTION

## BACKGROUND OF THE INVENTION

- motivate need for antisense agents

## SUMMARY OF THE INVENTION

- introduce GPNA oligonucleotides

## DESCRIPTION OF THE PREFERRED EMBODIMENT(S)

- describe GPNA structure
- explain PTD positioning
- detail EGFRAS GPNA oligonucleotides

### GRCARTCRGCRTGRCTRCCRCCRG (SEQ ID NO:6);

- provide alternative sequence

### CRCTRCCRGTRGGRTCRATRGCRTCRC (SEQ ID NO:8),

- provide additional alternative sequence

### CRGGRAGRGGRTCRGCRATRCGRCTRG (SEQ ID NO:10).

- provide additional alternative sequence

## Example 1

- describe in vivo antitumor efficacy study

## Example 2

- describe systemic delivery of EGFRAS GPNA study

